![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 5
2022
Wirth, Anna-Katharina; Wange, Lucas; Vosberg, Sebastian; Henrich, Kai-Oliver; Rausch, Christian; Oezdemir, Erbey; Zeller, Christina M.; Richter, Daniel; Feuchtinger, Tobias; Kaller, Markus; Hermeking, Heiko; Greif, Philipp A.; Senft, Daniela; Jurinovic, Vindi; Bahrami, Ehsan; Jayavelu, Ashok Kumar; Westermann, Frank; Mann, Matthias; Enard, Wolfgang; Herold, Tobias und Jeremias, Irmela
(2022):
In vivo PDX CRISPR/Cas9 screens reveal mutual therapeutic targets to overcome heterogeneous acquired chemo-resistance.
In: Leukemia, Bd. 36: S. 2863-2874
Carlet, Michela; Schmelz, Karin; Vergalli, Jenny; Herold, Tobias; Senft, Daniela; Jurinovic, Vindi; Hoffmann, Thomas; Proba, Jutta; Weichert, Nina; Junghanss, Christian; Roth, Mareike; Eschenburg, Georg; Barz, Malwine; Henze, Guenter; Eckert, Cornelia; Eggert, Angelika; Zuber, Johannes; Hundsdoerfer, Patrick und Jeremias, Irmela
(2022):
X-linked inhibitor of apoptosis protein represents a promising therapeutic target for relapsed/refractory ALL.
In: EMBO Molecular Medicine, Bd. 15, Nr. 1, e14557
2021
Liu, Wen-Hsin; Völse, Kerstin; Senft, Daniela und Jeremias, Irmela
(2021):
A reporter system for enriching CRISPR/Cas9 knockout cells in technically challenging settings like patient models.
In: Scientific Reports, Bd. 11, Nr. 1, 12649
2019
Senft, Daniela und Jeremias, Irmela
(2019):
A rare subgroup of leukemia stem cells harbors relapse-inducing potential in acute lymphoblastic leukemia.
In: Experimental Hematology, Bd. 69: S. 1-10
2012
Senft, Daniela; Berking, Carola; Graf, Saskia A.; Kammerbauer, Claudia; Ruzicka, Thomas und Besch, Robert
(2012):
Selective induction of cell death in melanoma cell lines through targeting of Mcl-1 and A1.
In: PLOS ONE 7(1), e30821 [PDF, 1MB]
In: PLOS ONE 7(1), e30821 [PDF, 1MB]